The clinical translation of nanomedicines for melanoma faces multiple challenges, including scalability and manufacturing complexities (e.g., difficulties in large-scale production of biomimetic nanoparticles under GMP standards), safety and immunogenicity concerns (such as unintended immune responses and limited long-term toxicity data), and biological barriers like tumor heterogeneity and the immunosuppressive TME
Remove needle cap
The peptide stimulates fat cells to break down stored triglycerides, releasing free fatty acids into the bloodstream where they can be used as fuel
Articles were excluded if they were not written in the English language, did not have a registered digital object identifier (DOI), were a letter to the editor or an abstract-only publication, did not directly assess the use of GLP-1 RAs in psoriasis or HS, were duplicate studies, or were inaccessible through institutional resources
You can go to the American Board of Obesity Medicine website and search for a physician who is board certified